Daily Stock Analysis, ICAD, ICAD Inc, priceseries

ICAD Inc. Daily Stock Analysis
Stock Information
Open
6.82
Close
6.86
High
6.91
Low
6.68
Previous Close
6.80
Daily Price Gain
0.06
YTD High
8.00
YTD High Date
Oct 22, 2019
YTD Low
3.52
YTD Low Date
Jan 3, 2019
YTD Price Change
3.09
YTD Gain
81.96%
52 Week High
8.00
52 Week High Date
Oct 22, 2019
52 Week Low
2.88
52 Week Low Date
Nov 19, 2018
52 Week Price Change
3.97
52 Week Gain
137.37%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 4. 2017
4.75
May 1. 2017
5.53
18 Trading Days
16.37%
Link
LONG
Sep 27. 2017
4.10
Oct 25. 2017
4.51
20 Trading Days
9.90%
Link
LONG
Feb 23. 2018
3.29
Mar 12. 2018
3.63
11 Trading Days
10.23%
Link
LONG
Nov 13. 2018
2.81
Dec 14. 2018
3.77
21 Trading Days
34.24%
Link
LONG
Jan 4. 2019
3.75
Jan 30. 2019
5.12
17 Trading Days
36.50%
Link
LONG
May 20. 2019
5.72
Jun 4. 2019
6.11
10 Trading Days
6.73%
Link
LONG
Sep 10. 2019
6.54
Sep 27. 2019
7.13
13 Trading Days
9.01%
Link
LONG
Oct 15. 2019
6.73
Oct 29. 2019
7.45
10 Trading Days
10.68%
Link
Company Information
Stock Symbol
ICAD
Exchange
NasdaqCM
Company URL
http://www.icadmed.com
Company Phone
603-882-5200
CEO
Kenneth M. Ferry
Headquarters
New Hampshire
Business Address
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH 03062
Sector
Equity
Industry Category
Computer Software & Services
Industry Group
Technical & System Software
CIK
0000749660
About

iCAD, Inc. engages in the provision of advanced image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and clinical decision support solutions for mammography, breast tomosynthesis, and computed tomography imaging. The Cancer Therapy segment offers an isotope-free cancer treatment platform technology. The company was founded in 1984 and is headquartered in Nashua, NH.

Description

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy. The company provides electronic brachytherapy (eBX) products, including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, cervical cancer, and skin cancer, as well as for treating other cancers or conditions where radiation therapy is indicated comprising intraoperative radiation therapy. It also offers digital mammography computer-aided detection (CAD) products, such as advanced image analysis and workflow solutions in breast imaging, which include PowerLook Mammo Detection, which detects and identifies suspicious masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer's network that receives patient studies from the imaging modality, performs CAD and density assessment analysis, and sends the CAD results to picture archiving and communication system and/or review workstations. In addition, the company's digital mammography CAD products comprise magnetic resonance imaging products to detect breast and prostate cancer; breast tomosynthesis systems; and advanced image analysis and workflow solutions in computed tomography (CT) colonography, including VeraLook that supports the detection of colonic polyps in conjunction with CT colonography. It serves hospitals, ambulatory care centers and free standing radiation oncology facilities, and other office-based uses through sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. The comapny has a strategic partnership agreement with Invivo Corp. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was founded in 1984 and is headquartered in Nashua, New Hampshire.